The present invention provides a pharmaceutical association and its use for converting tumor cells to non-tumor cells. The disclosure inhibits at least one growth factor receptor binding compound that activates at least one growth factor receptor of a tumor cell and at least one transmembrane cell adhesion protein of the tumor cell. A pharmaceutical association is provided comprising at least one adhesion protein inhibitor. [Selection] Figure 1【課題】腫瘍細胞を非腫瘍細胞に変換するための医薬的連合体及びその使用の提供。【解決手段】本開示は、腫瘍細胞の少なくとも１種の成長因子受容体を活性化させる少なくとも１種の成長因子受容体結合化合物と、前記腫瘍細胞の少なくとも１つの膜貫通細胞接着タンパク質を阻害する少なくとも１種の接着タンパク質阻害剤とを含む医薬的連合体を提供する。【選択図】図１
